Warrant exercises lift IRSA (NYSE: IRS) to 810.8M shares outstanding

Rhea-AI Filing Summary

IRSA Inversiones y Representaciones S.A. will register 36,606,967 new ordinary shares of ARS 10 par value after warrant exercises completed between February 17 and 25, 2026. These exercises generated cash proceeds of USD 608,565 for the company.

The total number of ordinary shares increased from 774,190,153 to 810,797,120, while outstanding warrants decreased from 53,161,206 to 26,392,876. Based on the current ratio of 1.6367 ordinary shares per warrant and an exercise price of USD 0.2641 per share, the company reports a fully diluted share count of 853,994,340, assuming all remaining warrants are exercised for cash.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 FORM 6-K

 REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15b-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2026

 IRSA Inversiones y Representaciones Sociedad Anonima

(Exact name of Registrant as specified in its charter)

IRSA Investments and Representations Inc.

(Translation of registrant´s name into English)

 Republic of Argentina

(Jurisdiction of incorporation or organization)

Carlos Della Paolera 261 9th Floor

(C1001ADA)

Buenos Aires, Argentina

 (Address of principal executive offices)

 Form 20-F ⌧ Form 40-F  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No x

IRSA INVERSIONES Y REPRESENTACIONES SOCIEDAD ANONIMA

(THE “COMPANY”)

REPORT ON FORM 6-K

Attached is an English translation of the letter dated March 11, 2026, filed by the Company with the Bolsa de Comercio de Buenos Aires and the Comisión Nacional de Valores.

Buenos Aires, March 11, 2026 – IRSA Inversiones y Representaciones S.A. (NYSE:IRS;BYMA:IRSA), informs that between February17 and 25, 2026, certain warrants holders have exercised their right to acquire additional shares.

Therefore, a total of 36,606,967 ordinary shares of the Company will be registered, with a face value of ARS 10. As a result of the exercise, USD 608,565 were collected by the Company.

After the exercise of these warrants, the number of shares of the Company increased from  774,190,153  to 810,797,120 with a face value of ARS 10, and the new number of outstanding warrants decreased from 53,161,206  to 26,392,876.

The following table provides a summary of the information regarding the options and shares issued by the Company:

Ordinary shares prior to Feb-2026 exercise	774,190,153
Warrants exercised in Feb-2026	26,768,330
Current Ratio (ordinary shares of face value of ARS 10 per warrant)	1.6367
Current exercise price (per ordinary share of face value of ARS 10)	USD 0.2641
Shares issued for Feb-2026 exercise*	36,606,967
Outstanding Warrants after Feb-2026 exercise	26,392,876
Shares to be issued upon warrant exercise	43,197,220
Outstanding ordinary shares after Feb-2026 exercise	810,797,120
Fully Diluted	853,994,340

*The amount includes rounding adjustments for each exercise instruction calculation.

**Assuming cash exercise.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Buenos Aires, Argentina.

	IRSA Inversiones y Representaciones Sociedad Anónima
	By:	/s/ Saúl Zang
		Saúl Zang
		Responsible for the Relationship with the Markets
March 11, 2026


 
 
 
 

FAQ

What did IRSA (IRS) announce in its March 2026 Form 6-K?

IRSA reported that warrant holders exercised rights between February 17 and 25, 2026, leading to the registration of 36,606,967 new ordinary shares. These exercises increased total shares outstanding and reduced the number of outstanding warrants while adding USD 608,565 in cash to the company.

How many new IRSA (IRS) shares were issued from the February 2026 warrant exercises?

IRSA states that 36,606,967 ordinary shares of ARS 10 face value were issued from warrant exercises in February 2026. This reflects the application of a 1.6367 share-per-warrant ratio and includes rounding adjustments applied to each individual exercise instruction.

How did the February 2026 warrant exercise affect IRSA (IRS) shares outstanding?

IRSA reports that ordinary shares outstanding rose from 774,190,153 to 810,797,120 after the February 2026 warrant exercises. This change reflects the issuance of new shares to warrant holders, increasing the company’s equity base compared with the pre-exercise position.

What cash proceeds did IRSA (IRS) receive from the February 2026 warrant exercises?

The company indicates it collected USD 608,565 from warrant holders exercising their rights between February 17 and 25, 2026. These proceeds result from the current exercise price of USD 0.2641 per ordinary share applied to the shares issued in that period.

How many IRSA (IRS) warrants were exercised and how many remain outstanding?

IRSA notes that 26,768,330 warrants were exercised in February 2026. After these transactions, outstanding warrants decreased from 53,161,206 to 26,392,876, leaving a significant number still available for future exercise into additional ordinary shares.

What is IRSA’s (IRS) fully diluted share count after the February 2026 warrant activity?

IRSA presents a fully diluted figure of 853,994,340 ordinary shares, assuming all remaining warrants are exercised for cash. This fully diluted number combines 810,797,120 outstanding ordinary shares with 43,197,220 additional shares issuable upon future warrant exercises.